Krystal Biotech Inc (KRYS)
171.06
-5.33
(-3.02%)
USD |
NASDAQ |
Nov 04, 16:00
171.06
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Price to Book Value: 5.858 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 6.041 |
| October 31, 2024 | 5.909 |
| October 30, 2024 | 6.012 |
| October 29, 2024 | 6.035 |
| October 28, 2024 | 6.058 |
| October 25, 2024 | 6.011 |
| October 24, 2024 | 5.992 |
| October 23, 2024 | 5.916 |
| October 22, 2024 | 6.000 |
| October 21, 2024 | 6.130 |
| October 18, 2024 | 6.137 |
| October 17, 2024 | 6.056 |
| October 16, 2024 | 6.088 |
| October 15, 2024 | 6.112 |
| October 14, 2024 | 6.150 |
| October 11, 2024 | 6.120 |
| October 10, 2024 | 5.93 |
| October 09, 2024 | 5.890 |
| October 08, 2024 | 5.988 |
| October 07, 2024 | 5.993 |
| October 04, 2024 | 6.066 |
| October 03, 2024 | 6.025 |
| October 02, 2024 | 6.075 |
| October 01, 2024 | 6.215 |
| September 30, 2024 | 6.234 |
| Date | Value |
|---|---|
| September 27, 2024 | 6.067 |
| September 26, 2024 | 6.110 |
| September 25, 2024 | 6.148 |
| September 24, 2024 | 6.146 |
| September 23, 2024 | 6.171 |
| September 20, 2024 | 6.307 |
| September 19, 2024 | 6.318 |
| September 18, 2024 | 6.258 |
| September 17, 2024 | 6.482 |
| September 16, 2024 | 6.653 |
| September 13, 2024 | 6.904 |
| September 12, 2024 | 6.700 |
| September 11, 2024 | 6.808 |
| September 10, 2024 | 6.336 |
| September 09, 2024 | 6.428 |
| September 06, 2024 | 6.308 |
| September 05, 2024 | 6.372 |
| September 04, 2024 | 6.368 |
| September 03, 2024 | 6.397 |
| August 30, 2024 | 6.682 |
| August 29, 2024 | 6.686 |
| August 28, 2024 | 6.983 |
| August 27, 2024 | 6.788 |
| August 26, 2024 | 6.867 |
| August 23, 2024 | 6.904 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.169
Minimum
Nov 26 2021
7.328
Maximum
Jun 13 2023
4.212
Average
3.956
Median
Price to Book Value Benchmarks
| Bioventus Inc | 5.920 |
| ADMA Biologics Inc | 23.68 |
| Axsome Therapeutics Inc | 40.68 |
| Amicus Therapeutics Inc | 25.37 |
| Sarepta Therapeutics Inc | 10.90 |
Price to Book Value Related Metrics
| PE Ratio | 46.74 |
| PS Ratio | 30.02 |
| Price | 171.06 |
| Earnings Yield | 2.14% |
| Market Cap | 4.915B |
| Operating PE Ratio | 1239.03 |
| Normalized PE Ratio | 102.30 |